|
NL154600B
(nl)
|
1971-02-10 |
1977-09-15 |
Organon Nv |
Werkwijze voor het aantonen en bepalen van specifiek bindende eiwitten en hun corresponderende bindbare stoffen.
|
|
JPS4843906B1
(https=)
*
|
1970-08-11 |
1973-12-21 |
|
|
|
NL154598B
(nl)
|
1970-11-10 |
1977-09-15 |
Organon Nv |
Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking.
|
|
NL154599B
(nl)
|
1970-12-28 |
1977-09-15 |
Organon Nv |
Werkwijze voor het aantonen en bepalen van specifiek bindende eiwitten en hun corresponderende bindbare stoffen, alsmede testverpakking.
|
|
US3901654A
(en)
|
1971-06-21 |
1975-08-26 |
Biological Developments |
Receptor assays of biologically active compounds employing biologically specific receptors
|
|
US3853987A
(en)
|
1971-09-01 |
1974-12-10 |
W Dreyer |
Immunological reagent and radioimmuno assay
|
|
US3867517A
(en)
|
1971-12-21 |
1975-02-18 |
Abbott Lab |
Direct radioimmunoassay for antigens and their antibodies
|
|
NL171930C
(nl)
|
1972-05-11 |
1983-06-01 |
Akzo Nv |
Werkwijze voor het aantonen en bepalen van haptenen, alsmede testverpakkingen.
|
|
US3850578A
(en)
|
1973-03-12 |
1974-11-26 |
H Mcconnell |
Process for assaying for biologically active molecules
|
|
US3935074A
(en)
|
1973-12-17 |
1976-01-27 |
Syva Company |
Antibody steric hindrance immunoassay with two antibodies
|
|
US3996345A
(en)
|
1974-08-12 |
1976-12-07 |
Syva Company |
Fluorescence quenching with immunological pairs in immunoassays
|
|
US4034074A
(en)
|
1974-09-19 |
1977-07-05 |
The Board Of Trustees Of Leland Stanford Junior University |
Universal reagent 2-site immunoradiometric assay using labelled anti (IgG)
|
|
US3984533A
(en)
|
1975-11-13 |
1976-10-05 |
General Electric Company |
Electrophoretic method of detecting antigen-antibody reaction
|
|
US4098876A
(en)
|
1976-10-26 |
1978-07-04 |
Corning Glass Works |
Reverse sandwich immunoassay
|
|
US4879219A
(en)
|
1980-09-19 |
1989-11-07 |
General Hospital Corporation |
Immunoassay utilizing monoclonal high affinity IgM antibodies
|
|
US5011771A
(en)
|
1984-04-12 |
1991-04-30 |
The General Hospital Corporation |
Multiepitopic immunometric assay
|
|
US4666828A
(en)
|
1984-08-15 |
1987-05-19 |
The General Hospital Corporation |
Test for Huntington's disease
|
|
US4683202A
(en)
|
1985-03-28 |
1987-07-28 |
Cetus Corporation |
Process for amplifying nucleic acid sequences
|
|
US4801531A
(en)
|
1985-04-17 |
1989-01-31 |
Biotechnology Research Partners, Ltd. |
Apo AI/CIII genomic polymorphisms predictive of atherosclerosis
|
|
US5272057A
(en)
|
1988-10-14 |
1993-12-21 |
Georgetown University |
Method of detecting a predisposition to cancer by the use of restriction fragment length polymorphism of the gene for human poly (ADP-ribose) polymerase
|
|
US5192659A
(en)
|
1989-08-25 |
1993-03-09 |
Genetype Ag |
Intron sequence analysis method for detection of adjacent and remote locus alleles as haplotypes
|
|
US5281521A
(en)
|
1992-07-20 |
1994-01-25 |
The Trustees Of The University Of Pennsylvania |
Modified avidin-biotin technique
|
|
WO1997044447A2
(en)
*
|
1996-05-03 |
1997-11-27 |
President And Fellows Of Harvard College |
Transcriptional activation system, activators, and uses therefor
|
|
US6861256B2
(en)
*
|
1997-05-15 |
2005-03-01 |
The General Hospital Corporation |
Therapeutic and diagnostic tools for impaired glucose tolerance conditions
|
|
GB9711148D0
(en)
*
|
1997-05-31 |
1997-07-23 |
Peptide Therapeutics Ltd |
Human MAFA
|
|
EP0928968A1
(en)
|
1998-01-12 |
1999-07-14 |
Universität Basel |
Screening method for apoptosis and necrosis
|
|
CA2443314C
(en)
|
2001-04-03 |
2006-03-21 |
The Board Of Trustees Of The Leland Stanford Junior University |
Method of imaging cell death in vivo
|
|
US20040204340A1
(en)
|
2003-04-11 |
2004-10-14 |
Guilford Pharmaceuticals, Inc. |
Polyprolyl inhibitors of cyclophilin
|
|
AU2005276117C1
(en)
*
|
2004-08-23 |
2013-04-18 |
Yeda Research And Development Co. Ltd. At The Weizmann Institute Of Science |
Peptide inhibitors for mediating stress responses
|
|
KR20070100832A
(ko)
*
|
2005-02-01 |
2007-10-11 |
아테뉴온, 엘엘씨 |
항혈관신생 ｐｈｓｃｎ 펩티드를 함유하는 조성물
|
|
US7704953B2
(en)
|
2006-02-17 |
2010-04-27 |
Mdrna, Inc. |
Phage displayed cell binding peptides
|
|
BR112012006005A2
(pt)
*
|
2009-09-17 |
2017-09-19 |
Univ Ramot |
"peptídeos no tratamento de transtorno associados ao estresse oxidativo"
|
|
WO2011126882A2
(en)
*
|
2010-03-30 |
2011-10-13 |
American Type Culture Collection |
Therapeutic peptides and their derivatives and therapeutic uses thereof
|
|
EP2593595B1
(en)
*
|
2010-07-16 |
2020-03-11 |
Avantgen, Inc. |
Novel peptides and uses thereof
|
|
PL2655612T3
(pl)
*
|
2010-12-23 |
2017-12-29 |
Shell Internationale Research Maatschappij B.V. |
Czynniki uszkadzające geny produkujące pochodne tłuszczowego acylo-coa
|
|
CA2836503C
(en)
|
2011-05-23 |
2020-09-22 |
Yeda Research And Development Co. Ltd. |
Use of akt phosphorylation as a biomarker for prognosing neurodegenerative diseases and treating same
|
|
US20140271666A1
(en)
*
|
2013-03-14 |
2014-09-18 |
Immune Pharmaceuticals Ltd. |
Use of anti-eotaxin antibodies for treating inflammatory bowel disease
|
|
CN104045703B
(zh)
*
|
2013-03-15 |
2021-04-06 |
深圳君圣泰生物技术有限公司 |
一种多肽、多肽衍生物、多肽的可药用盐及药物组合物
|
|
US8802633B1
(en)
|
2013-03-18 |
2014-08-12 |
Board Of Regents, The University Of Texas System |
Autophagy-inducing peptide analogs
|
|
EP3169343B1
(en)
*
|
2014-07-15 |
2020-03-25 |
Yissum Research and Development Company of the Hebrew University of Jerusalem Ltd. |
Isolated polypeptides of cd44 and uses thereof
|
|
US9453061B2
(en)
*
|
2014-08-06 |
2016-09-27 |
Brown University |
Method and compositions for treatment of calcineurin-related diseases
|
|
BR112017022845A2
(pt)
|
2015-04-23 |
2018-07-17 |
Nantomics, Llc |
neoepítopos de câncer
|
|
WO2017011338A1
(en)
|
2015-07-10 |
2017-01-19 |
President And Fellows Of Harvard College |
Sortase-mediated coupling of immunogenic polysaccharide-protein conjugates and their use
|
|
IL280101B2
(en)
|
2018-07-11 |
2025-05-01 |
Immunity Pharma Ltd |
Peptide compounds and their therapeutic uses
|
|
IL272074B2
(en)
|
2020-01-15 |
2024-12-01 |
Immunity Pharma Ltd |
Peptide compounds and methods of treating diseases using same
|